Gilead signals major hep C trouble ahead with sales guidance tweak

27th October 2017 Uncategorised 0

Gilead’s doing its best to move away from hepatitis C. But as usual, it was that topic that dominated the discussion on Thursday’s third-quarter earnings call—and it wasn’t a positive discussion.

More: Gilead signals major hep C trouble ahead with sales guidance tweak
Source: fierce